DRW3 Drägerwerk AG & Co. KGaA

127.23USD116.00 EUR · XETRA-2.52%Mkt Cap: 2.39B USDP/E: 12.86

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, p…

Institutional holders10 on file

Key Statistics

Company
Market Cap2.39B USD
Enterprise Value2.50B USD
Revenue (TTM)3.94B USD
Gross Profit1.73B USD
Net Income (TTM)153.00M USD
Revenue/Share210.66 USD
Last Price127.23 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees16.7K
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINDE0005550636
Valuation
P/E (Trailing)12.86
P/E (Forward)12.84
PEG—
EV/EBITDA6.73
EV/Revenue0.64
P/S0.61
P/B1.28
EPS (TTM)9.89 USD
EPS (Forward)9.91 USD
52W Range
72.3984% of range137.54
52W High137.54 USD
52W Low72.39 USD
Profitability
Gross Margin45.22%
Oper. Margin7.08%
EBITDA Margin9.44%
Profit Margin4.01%
ROE8.58%
ROA4.41%
ROIC8.59%
ROCE10.44%
Growth
Revenue Growth2.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF261.40M USD
CapEx (TTM)88.49M USD
FCF Margin4.50%
FCF Yield7.43%
Net Debt101.10M USD
Net Debt/EBITDA0.27
Net Debt/FCF0.57
Balance Sheet
Debt/Equity0.25
Current Ratio2.07
Quick Ratio1.13
Book Value/Sh99.31 USD
Cash/Share15.73 USD
Dividends
Fwd Div Rate2.49 USD
Trail. Div Rate2.49 USD
Div. Yield2.03%
5Y Avg Yield0.71%
Payout Ratio25.17%
Ex-Div DateMay 11, 2026
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)130.96 USD
Upside (mean)+2.9%
Target Range98.71 USD – 171.10 USD
98.71+2.9% to mean171.10
# Analysts5
Ownership
Shares Out.8.60M
Float11.56M
Insiders0.00%
Institutions33.66%
Technical
SMA 50120.84 (+5.3%)
SMA 200107.27 (+18.6%)
Beta0.56
S&P 52W Chg12.00%
Avg Vol (30d)24.07K
Avg Vol (10d)19.28K
Technical Indicators
RSI (14)61.5
MACD1.9503
MACD Signal0.1340
MACD Hist.+1.8163
BB Upper128.74 USD
BB Middle116.83 USD
BB Lower104.91 USD
BB Width20.40%
ATR (14)4.491 USD
Vol Ratio (20d)1.47x

About Drägerwerk (ETR: DRW3)

›

Drägerwerk (ETR: DRW3) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 16,716 employees.

The shares were at 116.00 EUR on 19 November 2026, up 69.8% over 52 weeks. Its 52-week range is 66.00 EUR to 125.40 EUR: the price is 7.5% below the high and 75.8% above the low.

At a market capitalisation of 2.18B EUR, it trades at 12.9 times trailing earnings and 12.8 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 50% for DRW3. It pays a dividend yielding 2.03% (it pays out 25% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Drägerwerk reports return on equity of 8.6%, an operating margin of 7.1% and revenue up 2.1% year over year.

Its debt exceeds its cash by 92.17M EUR, a debt-to-equity ratio of 0.25. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 119.40 EUR is 2.9% above the current price.